Neostigmine
Composition
It belongs to the cholinesterase inhibitor 2.5mg of Neostigmine Methylsulfate, 1 ampoule, and 3.54 mg sodium.
Indications
Myasthenia gravis, underactive urinary bladder, and Ogilvie syndrome.
Side effects
Allergic reaction, headache, fever, and blurred vision
Precautions
Pregnant, lactating mothers and those trying to get pregnant are suggested to decline its use.
Contraindications
If undergoing any disorders like kidney blockage and intestine blockage one is suggested to consult
Dosage and administration
Form of medicine- Injection, in the proportion-0.5 to 2.5 mg, should be inserted directly into veins.
Countries
We are a pharmaceutical manufacturer and provider in Lesotho, Honduras, Madagascar, Tonga, Guyana, and Martinique.
Available Forms
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai